Literature DB >> 15094711

Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus.

Yinghao Su1, Xiaoxin Chen, Michael Klein, Ming Fang, Su Wang, Chung S Yang, Raj K Goyal.   

Abstract

In rats, esophagogastroduodenal anastomosis (EGDA) without concomitant chemical carcinogen treatment can lead to columnar-lined esophagus (CLE) including metaplasia, dysplasia, and esophageal adenocarcinoma (EAC). This study describes the morphology and phenotypic features of CLE and EAC in the rat model and compares them with the corresponding lesions in human Barrett's esophagus (BE). Swiss roll preparations of esophagi of EGDA rats and biopsies from human BE containing specialized intestinal metaplasia (SIM) and EAC were examined. The esophagi of EGDA rats showed esophagitis, CLE, islands of multilayered epithelium (MLE), dysplasia and EAC. The CLE had features of specialized intestinal metaplasia. MLE frequently occurred at the neo-squamocolumnar junction and occasionally in the mid-esophagus in isolated foci. Scattered mucinous cells in esophageal squamous epithelium were also found. The CLE and MLE in EGDA rats resembled the lesions described in human BE in morphology, mucin features and expression of differentiation markers (CK7, CK20, Das-1, villin, and pS2/TFF1). Invasive EAC in EGDA rat is of well-differentiated mucinous type, which is in contrast to the variably differentiated glandular type of adenocarcinoma in human BE. p53, c-myc, and cyclooxygenase 2 are expressed in both the rat and human SIM and EAC. These studies indicate that, not withstanding small differences, SIM and EAC induced in EGDA rats are similar to the corresponding lesions in human BE. EGDA rats may serve as a useful model to study the pathogenesis, molecular biology, and chemopreventive interventions of human BE and EAC.

Entities:  

Mesh:

Year:  2004        PMID: 15094711     DOI: 10.1038/labinvest.3700079

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  26 in total

Review 1.  New models of neoplastic progression in Barrett's oesophagus.

Authors:  Kirill Pavlov; Carlo C Maley
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

2.  Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.

Authors:  H Kazumori; S Ishihara; M A K Rumi; Y Kadowaki; Y Kinoshita
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

3.  Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.

Authors:  Jing Hao; Bin Zhang; Ba Liu; Maojung Lee; Xingpei Hao; Kenneth R Reuhl; Xiaoxin Chen; Chung S Yang
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

4.  Development and characterization of an organotypic model of Barrett's esophagus.

Authors:  Rachelle E Kosoff; Kristin L Gardiner; Lauren M F Merlo; Kirill Pavlov; Anil K Rustgi; Carlo C Maley
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

5.  Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.

Authors:  Yun-Xiang Chu; Wei-Hong Wang; Yun Dai; Gui-Gen Teng; Shu-Jun Wang
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 6.  The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms.

Authors:  Roy C Orlando
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

7.  Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting.

Authors:  Tomoharu Miyashita; Furhawn A Shah; Guy Marti; Jiaai Wang; Todd Armstrong; Pramod Bonde; Michael K Gibson; Kiyoshi Yoshimura; Elizabeth A Montgomery; Mark D Duncan; Elizabeth M Jaffee; John W Harmon
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

8.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

9.  Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.

Authors:  Paula Esquivias; Antonio Morandeira; Alfredo Escartín; Carmelo Cebrián; Sonia Santander; Francisco Esteva; María Asunción García-González; Javier Ortego; Angel Lanas; Elena Piazuelo
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

10.  Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.

Authors:  Jing Hao; Ba Liu; Chung S Yang; Xiaoxin Chen
Journal:  BMC Gastroenterol       Date:  2009-07-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.